Literature DB >> 268982

Chromosomes and causation of human cancer and leukemia. XXIV. Unusual and complex Ph1 translocations and their clinical significance.

S I Sonta, A A Sandberg.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 268982

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

2.  Transposition of 9q34 and 22 (q11toqter) regions has a specific role in chronic myelocytic leukemia.

Authors:  F Pasquali; R Casalone; D Francesconi; D Peretti; M Fraccaro; C Bernasconi; M Lazzarino
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

3.  A nine-year cytogenetic follow-up of a patient injected with Thorotrast.

Authors:  T Ishihara; S Kohno; I Hayata; T Kumatori
Journal:  Hum Genet       Date:  1978-05-16       Impact factor: 4.132

4.  Translocation between chromosome 7 and chromosome 22, t(7;22)(p22;q12), in a patient with chronic myelocytic leukemia.

Authors:  G Gahrton; K Friberg; L Zech
Journal:  Hum Genet       Date:  1979-06-19       Impact factor: 4.132

Review 5.  Karyotypic progression in human tumors.

Authors:  S R Wolman
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Chronic myelogenous leukemia with translocations (3q-;9q+) and (17q-;22q+). Possible crucial cytogenetic events in the genesis of CML.

Authors:  M Oshimura; K Ohyashiki; M Vehara; Y Miyasaka; S Osamura; A Tonomura
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  New complex Ph' translocation t (10; 14; 22) in bone marrow cells and in PHA-stimulated peripheral blood cultures in chronic myelocytic leukaemia.

Authors:  F Shabtai; U Gafter; S Weiss; M Djaldetti; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.